Leptin, adiponectin, and high-sensitivity C-reactive protein in relation to the metabolic syndrome in Urban South African blacks with and without coronary artery disease

Metabolic Syndrome and Related Disorders

Volumn 7, Issue 3, 2009, Pages 243-248

  Ntyintyane, Lucas ^a   Panz, Vanessa ^a   Raal, Frederick J ^a,c   Gill, Geoffrey ^b  

^a UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^b LIVERPOOL SCHOOL OF TROPICAL MEDICINE   (United Kingdom)

^c UNIVERSITY OF THE WITWATERSRAND MEDICAL SCHOOL   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; ANTIHYPERTENSIVE AGENT; C REACTIVE PROTEIN; LEPTIN;

ADULT; ARTICLE; BODY MASS; CLINICAL ARTICLE; CLINICAL EVALUATION; COMPARATIVE STUDY; CONTROL GROUP; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DISEASE COURSE; DISEASE MARKER; FEMALE; HUMAN; HYPERTENSION; INFLAMMATION; MALE; METABOLIC SYNDROME X; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SOUTH AFRICA; URBAN POPULATION; WAIST CIRCUMFERENCE;

ADIPONECTIN; ADULT; BIOLOGICAL MARKERS; BODY MASS INDEX; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; CORONARY ARTERY DISEASE; FASTING; FEMALE; HUMANS; INFLAMMATION MEDIATORS; LEPTIN; LINEAR MODELS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; SEX CHARACTERISTICS; SOUTH AFRICA; URBAN POPULATION; WAIST CIRCUMFERENCE;

EID: 66149160488     PISSN: 15404196     EISSN: None     Source Type: Journal    
DOI: 10.1089/met.2008.0080     Document Type: Article

References (34)

1. Alberti KG, Zimmet P, Shaw J for the IDF Epidemiology Task Force Consensus Group: The metabolic syndrome-a new worldwide def nition. Lancet 2005;366:1059-1062.
2. Lee CM, Huxley RR, Woodward M, Zimmet P, Shaw J, Cho NH, et al. on behalf of the Detect-2 Collaboration: Comparisons of metabolic syndrome def nitions in four populations of the Asia-Pacif c region. Metab Synd Relat Disord 2008;6:37-46.
3. Al-Qahtani DA, Imtiaz ML, Saad OS, Hussein NM. A comparison of the prevalence of metabolic syndrome in Saudi adult females using two def nitions. Metab Synd Relat Disord 2006;4:204-214.
4. Mahadik SR, Deo SS, Mehtalia SD. Increased prevalence of metabolic syndrome in non-obese Asian Indians-an urban-rural comparison. Metab Synd Relat Disord 2007;5:142-152.
5. Kraja AT, Hunt SC, Pankow JS, Myers RH, Heiss G, Lewis CE, et al. An evaluation of the metabolic syndrome in the HyperGEN study. Nutr Metab 2005;2:2.
6. Ntyintyane LM, Panz VR, Raal FJ, Gill GV. The metabolic syndrome using the National Cholesterol Education Program and International Diabetes Federation def nitions among urbanised black South Africans with established coronary artery disease. JEMDSA 2007;12:6-12.
7. Seftel HC. The rarity of coronary artery disease in South African blacks. S Afr Med J 1978;54:99-105.
8. Vorster HH. The emergence of cardiovascular disease during urbanisation of Africans. Publ Hlth Nutr 2002;5:239-243.
9. Amira C, Ntyintyane L, Wilkinson D, Stewart S, Becker A, Libhaber E, et al. Emerging epidemic of cardiovascular disease among urban Africans: acute coronary syndrome at Baragwanath Hospital, Soweto. S Afr Heart J 2006; 3:7-12.
10. Sliwa K, Wilkinson D, Hansen C, Ntyintyane L, Tibazarwa K, Becker A, et al. Spectrum of heart disease and risk factors in a black urban population in South Africa (the Heart of Soweto Study): a cohort study. Lancet 2008;371:915-922.
11. Ntyintyane LM, Panz VR, Raal FJ, Gill GV. Postprandial lipae-mia, metabolic syndrome and LDL particle size in urbanised South African blacks with and without coronary artery disease. Q J Med 2008;101:111-119.
12. Ntyintyane LM, Panz VR, Raal FJ, Gill GV. Postprandial hyper-glycemia in urban South African blacks with and without coronary artery disease. Metab Synd Relat Disord 2009;7:23-29.
13. Lakka HM, Laaksonen DE, Lakka TA, Niskanen LK, Kumpusalo E, Tuomilehto J, et al. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. J Am Med Assoc 2002;288:2709-2716.
14. Isomaa B, Almgren P, Tuomi T, Forsén B, Lahti K, Nissén M, et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabet Care 2001;24:683-689.
15. Theuma P, Fonseca VA. Inf ammation, insulin resistance, and atherosclerosis. Metab Synd Relat Disord 2004;2:105-113.
16. Libby P. Inf ammation in atherosclerosis. Nature 2002;420: 868-874.
17. Hansson GK. Inf ammation, atherosclerosis and coronary artery disease. N Engl J Med 2005;352:1685-1695.
18. Sutherland J P, McKinley B, Eckel RH. The metabolic syndrome and inf ammation. Metab Synd Relat Disord 2004;2:82-104.
19. Das UN. Is obesity an inf ammatory condition? Nutrition 2001;17:953-966.
20. Fantuzzi G. Adipose tissue, Adipokines, and inf ammation. J Allergy Clin Immunol 2005;115:911-919.
21. Flier JS. What's in a name? In search of leptin's physiologic role. J Clin Endocrinol Metab 1998;83:1407-1413.
22. Arita Y, Kihara S, Ouchi N, Takahashi M, Maeda K, Miyagawara J, et al. Paradoxical decrease of an adipose-specif c protein, adi-ponectin, in obesity. Biochem Biophys Res Comm 1999;257:79-83.
23. Ablij H, Meinders A. C-reactive protein: history and revival. Eur J Intern Med 2002;13:412.
24. Ma Z, Gingerich RL, Santiago J V, Klein S, Smith CH, Landt M. Radioimmunoassay of leptin in human plasma. Clin Chem 1996;42:942-946.
25. Ntyintyane LM, Panz VR, Raal FJ, Gill GVL. Metabolic syndrome, undiagnosed diabetes mellitus and insulin resistance are highly prevalent in urbanised South African blacks with coronary artery disease. Cardiovasc J South Afr 2006;17:50-55.
26. Laaksonen DE, Niskanen L, Nyyssönen K, Punnonen K, Tuomainen TP, Valkonen V P, et al. C-reactive protein and the development of the metabolic syndrome and diabetes in middle-aged men. Diabetologia 2004;47:1403-1410.
27. Lee WY, Park JS, Noh SY, Rhee EJ, Sung KC, Kim BS, et al. C-reactive protein concentrations are related to insulin resistance and metabolic syndrome as def ned by the ATP III report. Int J Cardiol 2004;97:101-106.
28. Florez H, Castillo-Florez S, Mendez A, Cassanova-Romero P, Larreal-Urdaneta C, et al. C-reactive protei n is elevated in obese patients with the metabolic syndrome. Diabetes Res Clin Pract 2006;71:92-100.
29. Wilson AM, Ryan MC, Boyle AJ. The novel role of C-reactive protein in cardiovascular disease: risk marker or pathogen. Int J Cardiol 2006;106:291-297.
30. Ostlund RE, Jr., Yang JW, Klein S, Gingerich R. Relation between plasma leptin concentration and body fat, gender, diet, age, and metabolic covariates. J Clin Endocrinol Metab 1996;81: 3909-3913.
31. Liuzzi A, Savia G, Tagliaferri M, Lucantoni R, Berselli ME, Petroni ML, et al. Serum leptin concentration in moderate and severe obesity: relationship with clinical, anthropometric and metabolic factors. Int J Obes Metab Disord 1999;23:1066-1073.
32. Van der Merwe M-T, Panz VR, Crowther NJ, Schlaphoff GP, Gray IP, Froguel P, et al. Free fatty acids and insulin levels- relationship to leptin levels and body composition in various patient groups from South Africa. Int J Obes 1999;23:909-917.
33. Fox CS, Massaro JM, Hoffmann U, Pou KM, Maurovitch-Horvat P, Liu CY, et al. Abdominal visceral and subcutaneous adipose tissue compartments: association with metabolic risk factors in the Framingham Heart Study. Circulation2007;116:39-48.
34. Onat A, Avci GS, Barlan MM, Uyarel H, Uzunlar B, Sansoy V. Measures of abdominal obesity assessed for visceral adiposity and relation to coronary risk. Int J Obes Relat Disord 2004;28:1018-1025.